Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Market Videos
Currencies
International
Treasury & Bonds
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
Dow Jones Industrial Average
NASDAQ Composite
Standard & Poors 500
NYSE COMPOSITE INDX
Gold
Crude Oil
Isis Pharmaceuticals, Inc.
(NQ:
ISIS
)
20.66
USD
+0.50 (+2.48%)
Official Closing Price
/ Updated:
8:10 PM EDT, May 17, 2013
/
Add to My Watchlist
View:
Quote
Overview
Detailed Quote
Charting
Options
Historical Prices
News
All News
Press Releases
Related Stories
Blogs
Podcasts
Research
Quarterly Reports
Insider Filings
Other Filings
Press releases about Isis Pharmaceuticals, Inc.
< Previous
1
2
3
4
5
6
7
8
9
...
18
19
Next >
Isis Pharmaceuticals to Present at the 2013 UBS Global Healthcare Conference
May 13, 2013
from
PR Newswire
Isis Pharmaceuticals Earns $3.5 Million from Biogen Idec
May 09, 2013
from
PR Newswire
Isis Pharmaceuticals to Present at the Bank of America Merrill Lynch 2013 Health Care Conference
May 09, 2013
from
PR Newswire
Isis Pharmaceuticals Prices Public Offering Of Common Stock
May 08, 2013
from
PR Newswire
Isis Pharmaceuticals Announces Proposed Public Offering of Common Stock
May 07, 2013
from
PR Newswire
Isis Reports Financial Results and Highlights for First Quarter 2013
May 07, 2013
- Conference Call Webcast Tuesday, May 7, 4:30 p.m. ET at www.isispharm.com
Read More
from
PR Newswire
Isis Pharmaceuticals Announces the Initiation of a Clinical Study of ISIS-STAT3 Rx in Patients with Liver Cancer
May 06, 2013
from
PR Newswire
Webcast Alert: Isis Pharmaceuticals' First Quarter 2013 Financial Results Conference Call
May 02, 2013
from
PR Newswire
Critical Alerts For Citigroup, ENSCO International, Hasbro, Isis Pharmaceuticals, and Cree Released By InvestorsObserver
April 23, 2013
from
PR Newswire
ISIS Pharmaceuticals Initiates a Clinical Study of ISIS-SMN Rx in Infants With Spinal Muscular Atrophy
April 23, 2013
Isis to Earn $3.5 Million Milestone Payment
Read More
from
PR Newswire
Isis Pharmaceuticals to Present at the 12th Annual Needham Healthcare Conference
April 22, 2013
from
PR Newswire
StockCall Scrutinizes Warner Chilcott, Dynavax Technologies, Isis Pharma, and United Therapeutics
April 11, 2013
from
PR Newswire
Roche and Isis Pharmaceuticals form alliance for Huntington's disease
April 08, 2013
from
PR Newswire
Isis Initiates Phase 1 Study of ISIS-APOA Rx to Treat Atherosclerosis
April 03, 2013
from
PR Newswire
Isis Publishes Data Demonstrating Antisense Targeting of ApoC-III Significantly Reduces ApoC-III and Triglycerides
April 01, 2013
Research Shows Antisense Inhibition of ApoC-III and Triglycerides in Multiple Species Including Humans
Read More
from
PR Newswire
Isis Provides Update on CHMP Opinion on KYNAMRO™ (mipomersen)
March 22, 2013
from
PR Newswire
Morning Winners - Affymax, Inc. (NASDAQ:AFFY), ACADIA Pharmaceuticals Inc, SUPERVALU INC, ISIS Pharmaceuticals Inc
March 21, 2013
from
SBWire Direct - Latest Press Releases
Data From ISIS-SMN Rx Phase 1 Study in Children With Spinal Muscular Atrophy Presented at the American Academy of Neurology Meeting
March 20, 2013
Isis to host an investor event and live webcast at 7:30 am PT on Thursday, March 21 in San Diego
Read More
from
PR Newswire
Isis Pharmaceuticals to Present at the 25th Annual ROTH Conference
March 15, 2013
from
PR Newswire
Isis Pharmaceuticals to Host Investor Event to Discuss ISIS-SMN Rx Data Presented at 2013 AAN Annual Meeting
March 14, 2013
- Event and webcast scheduled on Thursday, March 21 at 7:30 a.m. Pacific Time
Read More
from
PR Newswire
Warner Chilcott, Dynavax Technologies, Isis Pharma, United Therapeutics, and Pharmacyclics Under StockCall's Microscope
March 13, 2013
from
PR Newswire
Isis Pharmaceuticals Reports Clinical Data Showing Blunting of Severe Increases in CRP Following Endotoxin Challenge With ISIS-CRP Rx
March 13, 2013
Up to 63% Reduction in CRP Response with ISIS-CRP Rx Treatment
Read More
from
PR Newswire
A forward Look into the Year Ahead - Research Report on Boyd Gaming Corporation, Ameristar Casinos, Inc., Aegerion Pharmaceuticals, Inc., ISIS Pharmaceuticals, Inc. and Avon Products, Inc.
March 12, 2013
from
PR Newswire
New Programs Designed to Speed Up Approval Process a Key Factor in Biotech Industry's Growth in 2012
March 07, 2013
Five Star Equities Provides Stock Research on Achillion Pharmaceuticals and ISIS Pharmaceuticals
Read More
from
Marketwired News Releases
Pipeline Initiatives, Partnerships to Drive Growth - Research Report on Pfizer, Theravance, ISIS Pharmaceuticals, Infinity Pharmaceuticals and Ironwood
March 07, 2013
from
PR Newswire
Isis Pharmaceuticals to Present at the Barclays Global Healthcare Conference
March 06, 2013
from
PR Newswire
Isis Reports Financial Results and Highlights for 2012
February 28, 2013
- Conference Call Webcast Thursday, February 28, 12:00 p.m. ET at www.isispharm.com
Read More
from
PR Newswire
Isis Pharmaceuticals To Present At The Cowen and Company 33rd Annual Health Care Conference
February 27, 2013
from
PR Newswire
Isis Pharmaceuticals Initiates Phase 2 Study Of ISIS-CRP Rx In Patients With Atrial Fibrillation
February 26, 2013
from
PR Newswire
Huntington’s Disease Therapeutic and Companion Biomarker Collaboration Forged by KineMed, Isis Pharmaceuticals, and CHDI Foundation
February 21, 2013
from
Business Wire News Releases
< Previous
1
2
3
4
5
6
7
8
9
...
18
19
Next >
Stock Market XML and JSON Data API
provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays.
Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.
Press Release Service
provided by PRConnect.
Stock quotes supplied by Telekurs USA
Postage Rates
Bots go here